These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5317782)

  • 1. The effect of nicotinic acid on the diurnal variation of the free fatty acids of plasma.
    Carlström S; Laurell S
    Acta Med Scand; 1968; 184(1-2):121-3. PubMed ID: 5317782
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.
    Carlson LA; Orö L; Ostman J
    J Atheroscler Res; 1968; 8(4):667-77. PubMed ID: 5679950
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia.
    Carlson LA; Orö L; Ostman J
    Acta Med Scand; 1968 May; 183(5):457-65. PubMed ID: 4883477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO
    Lakartidningen; 1971 Apr; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hyperlipemias with lipolytic drugs].
    Jover Sanz E; Paradinas Jiménez C; Corporales López L; Martínez Robles JV
    Rev Clin Esp; 1974 Jun; 133(5):447-50. PubMed ID: 4428087
    [No Abstract]   [Full Text] [Related]  

  • 7. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.
    Schlierf G; Dorow E
    J Clin Invest; 1973 Mar; 52(3):732-40. PubMed ID: 4685092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal inhibition of lipolysis in man by nicotinic acid and derivatives.
    Kruse W; Kruse W; Raetzer H; Heuck CC; Oster P; Schellenberg B; Schlierf G
    Eur J Clin Pharmacol; 1979 Aug; 16(1):11-5. PubMed ID: 499296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.
    Lipson MJ; Naimi S; Proger S
    Metabolism; 1971 Jun; 20(6):580-9. PubMed ID: 5578972
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administration.
    Avogaro P; Bittolo-Bon G; Cazzolato G
    Pharmacol Res Commun; 1978 Feb; 10(2):127-31. PubMed ID: 349572
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nicotinic acid on muscle lipid concentration in man.
    Fröberg SO; Castenfors H
    Acta Med Scand; 1974; 196(1-2):65-7. PubMed ID: 4418517
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia.
    Kissebah AH; Adams PW; Harrigan P; Wynn V
    Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and tissue lipid metabolism and effect of nicotinic acid in different types of hyperlipidemia.
    Carlson LA; Walldius G
    Adv Exp Med Biol; 1972; 26(0):165-78. PubMed ID: 4370366
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of nicotinic acid upon the disturbances in lipid metabolism caused by carbon disulphide in rats.
    Wrońska-Nofer T
    Int Arch Arbeitsmed; 1970; 27(3):221-7. PubMed ID: 5490373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Daily profile of blood lipids under standardized diet with and without nicotinic acid].
    Mühlfellner G; Mühlfellner O; Zöfel P; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():810-2. PubMed ID: 1029288
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.